Eptacog Alfa Recombinant Human Coagulation Factor VIIa Market Industry Share, Size: 2022 Market Research with Growth, Manufacturers, Segments and Forecast – 2028

 

The global eptacog alfa recombinant human coagulation factor VIIa market is expected to grow at a significant CAGR during the forecast period (2022-2028). The vitamin K-dependent glycoprotein recombinant factor VIIa (NovoSeven) [also known as recombinant activated factor VII or eptacog alfa] is structurally similar to human plasma-derived factor VIIa. It’s a recombinant product created through DNA biotechnology. In patients with certain bleeding disorders, intravenous recombinant factor VIIa has been tested for treating bleeding episodes and providing haemostasis cover during surgery. Owing to the rarity of these bleeding disorders, large, well-controlled trials of recombinant factor VIIa have not been conducted.

Some of the key players profiled in the study are Novo Nordisk AS, Pfizer Inc., and Biogen Inc., among others.

Eptacog Alfa Recombinant Human Coagulation Factor VIIa Market Segmentation:

By Type 

• 60 KIU 
• 50 KIU

By Application 

• Bleeding 
• Surgery Assisted
• Glanzmann Plateletasthenia
• Hemophilia B
• Hemophilia A
• Head Trauma 
• Others

Geographic Coverage

• North America Market Size and/or Volume
• Latin America Market Size and/or Volume
• Europe Market Size and/or Volume
• Asia-Pacific Market Size and/or Volume
• Rest of the world Market Size and/or Volume

Key questions answered in this report:

• What is the size of the Eptacog Alfa Recombinant Human Coagulation Factor VIIa market and what is its expected growth rate?
• What are the primary driving factors that push the Eptacog Alfa Recombinant Human Coagulation Factor VIIa Market forward?
• What are the Eptacog Alfa Recombinant Human Coagulation Factor VIIa Industry’s top companies?
• What are the different categories that the Eptacog Alfa Recombinant Human Coagulation Factor VIIa Market caters to?
• What will be the fastest-growing segment or region?
• In the value chain, what role do essential players play?
• What is the procedure for getting a free copy of the Eptacog Alfa Recombinant Human Coagulation Factor VIIa Market sample report and company profiles?